Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
Donoghoe Nicholas has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Donoghoe Nicholas is listed as EVP, CHIEF BUS/STRAT OFFICER at AbbVie Inc. Inside the rolling window, Donoghoe Nicholas reported no open-market purchases and 1 open-market sale totaling $8.2M in ABBV.
Companies traded
Other insiders at ABBV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Donoghoe Nicholas made?
Donoghoe Nicholas has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Donoghoe Nicholas trade?
Donoghoe Nicholas has filed SEC Form 4 disclosures for 1 company, including ABBV.
When was Donoghoe Nicholas's most recent SEC Form 4 filing?
Donoghoe Nicholas's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Donoghoe Nicholas's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Donoghoe Nicholas is listed as EVP, CHIEF BUS/STRAT OFFICER.
What is Donoghoe Nicholas's total buy and sell value in the current window?
Inside the rolling retention window, Donoghoe Nicholas bought $0 and sold $8.2M based on SEC Form 4 filings.
What was Donoghoe Nicholas's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 32,710 ABBV shares on 2026-08-14, worth $8.2M, per SEC Form 4 filings.